首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › CLDX

SUPERSTRING CAPITAL MANAGEMENT LP 对 CLDX 的持仓历史

CELLDEX THERAPEUTICS INC NEW · 医疗保健

SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 CLDX(CELLDEX THERAPEUTICS INC NEW)287,583 股,市值约 US$10.7M,约占其申报组合的 6.76%,在其申报持仓中市值排名第 4 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 3 个申报季度中有 3 个季度披露了 CLDX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)287.58K 股
申报持仓市值$10.70M
组合权重6.76%
首次申报Q4 2025
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

SUPERSTRING CAPITAL MANAGEMENT LP 对 CLDX 的持仓演变

SUPERSTRING CAPITAL MANAGEMENT LP 于 Q4 2025 首次披露 CLDX 持仓:88,308 股(约 US$2.4M)。 该持仓在 Q2 2026 达到峰值 287,583 股,市值约 US$10.7M。 在 3 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 287,583 股、市值约 US$10.7M,环比增持 107,535 股。。 持仓曾出现大幅变动:Q1 2026 增持约 104% (随后一个季度股价上涨 17%)、Q2 2026 增持约 60% (随后一个季度股价下跌 13%)。

逐季持仓明细

季度股数金额变化
Q4 2025 88.31K $2.40M 新进
Q1 2026 180.05K $5.71M 增持
Q2 2026 287.58K $10.70M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CLDX 与 13F 数据

CLDX(CELLDEX THERAPEUTICS INC NEW)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 CLDX,申报仓位最大的包括:Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CLDX 的基金

查看 CLDX 的全部基金持有人 →

常见问题

How long has SUPERSTRING CAPITAL MANAGEMENT LP held CLDX?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLDX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in CLDX?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 287.58K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $10.70M, representing 6.76% of its reported portfolio and ranking #4.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling CLDX?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in CLDX. The position peaked in Q2 2026 at 287.58K shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.